# NTHL1

## Overview
NTHL1 is a gene that encodes the protein nth like DNA glycosylase 1, which is a crucial component of the base excision repair (BER) pathway. This protein is categorized as a bifunctional DNA glycosylase, responsible for identifying and excising oxidized pyrimidine bases, thereby maintaining genomic stability by preventing mutations. The NTHL1 protein features a helix-hairpin-helix (HhH) DNA binding motif and a [4Fe-4S] cluster, which are essential for its DNA repair functions. It operates primarily in the nucleus but also plays a role in mitochondrial DNA maintenance, influencing cellular resilience to oxidative stress. Mutations in the NTHL1 gene are linked to NTHL1-related tumor syndrome, a hereditary condition associated with an increased risk of various cancers, including colorectal and breast cancer (Hubers2024Functional; Weren2017NTHL1; Das2020NTHL1).

## Structure
The human NTHL1 protein is a bifunctional DNA glycosylase involved in the base excision repair pathway, responsible for repairing oxidized pyrimidine substrates. Its structure includes a helix-hairpin-helix (HhH) DNA binding motif, which is crucial for its function. The protein features a six-helical barrel domain and an iron-sulfur cluster-containing domain, with a flexible interdomain linker that facilitates an open conformation necessary for catalysis (Carroll2021Caught). This open conformation is characterized by a significant separation of catalytic residues, Lys 220 and Asp 239, which are approximately 23 Å apart, unlike the ~5 Å separation seen in bacterial homologs (Carroll2021Caught).

The NTHL1 protein also has a disordered N-terminal extension, which includes nuclear and mitochondrial localization sequences and is involved in protein-protein interactions (Carroll2021Caught). The flexibility of the protein is attributed to the interdomain linker, which is not highly conserved across species, suggesting evolutionary adaptation for its function in humans (Carroll2021Caught). The protein's structure and flexibility are critical for its DNA binding and catalytic activities, with mutations near the linker regions potentially affecting its function and contributing to cancer-related variants (Carroll2021Caught).

## Function
The NTHL1 gene encodes a bifunctional DNA glycosylase that plays a critical role in the base excision repair (BER) pathway, which is essential for maintaining genomic stability by repairing oxidative DNA base damage. NTHL1 recognizes and excises oxidized pyrimidine bases, such as thymine glycol, initiating the BER process by cleaving the N-glycosidic bond of damaged bases. This action creates an apurinic/apyrimidinic (AP) site, which is further processed by other enzymes to complete the repair (Limpose2018Overexpression; Das2020NTHL1).

NTHL1 is primarily active in the nucleus, where it helps protect DNA from oxidative damage, thus preventing mutations and maintaining genomic integrity (Ikeda1998Purification). The enzyme's activity is facilitated by a [4Fe-4S] cluster, which is crucial for its function (Ikeda1998Purification). NTHL1 also plays a role in mitochondrial DNA maintenance, influencing mitochondrial dynamics and energy metabolism. Its deficiency can lead to increased mitochondrial DNA damage and altered mitochondrial function, indicating its importance in cellular resilience to oxidative stress (Hubers2024Functional). The gene's function is vital in preventing diseases such as cancer, as defects in DNA repair pathways involving NTHL1 can lead to increased mutagenesis and genomic alterations (Das2020NTHL1).

## Clinical Significance
Mutations in the NTHL1 gene are associated with NTHL1-related tumor syndrome, a rare hereditary condition that follows an autosomal recessive inheritance pattern. This syndrome is characterized by an increased lifetime risk for colorectal cancer (CRC), breast cancer, and other malignancies, as well as adenomatous polyposis (Weren2017NTHL1; Magrin2021POLE). The condition is linked to biallelic pathogenic variants in the NTHL1 gene, with the p.Gln90* nonsense mutation being a notable example (Weren2017NTHL1; Boulouard2021Further).

Individuals with NTHL1-associated polyposis often develop multiple adenomatous polyps and mismatch repair-proficient CRC, with some also developing other cancers such as meningiomas, bladder cancer, basal cell carcinoma, and endometrial cancer (Weren2017NTHL1; Pinto2023Combined). The syndrome is characterized by a specific mutational signature, 'signature 30', which involves C>T transitions and is found in multiple tumors across different organs in affected individuals (Magrin2021POLE).

Heterozygous carriers of NTHL1 pathogenic variants do not show an increased risk for CRC, but there may be a low to moderate increased risk for breast cancer (Nurmi2023NTHL1; Magrin2021POLE). The prevalence of NTHL1 tumor syndrome is estimated to be less common than MUTYH-associated polyposis (Weren2017NTHL1).

## Interactions
NTHL1, a DNA glycosylase involved in the base excision repair (BER) pathway, participates in several protein-protein interactions that influence genomic stability. One significant interaction is with XPG, a protein involved in nucleotide excision repair and homologous recombination (HR). Overexpression of NTHL1 can sequester XPG, potentially hindering HR repair of double-strand breaks (DSBs) and leading to genomic instability. This interaction is independent of oxidative DNA damage, as demonstrated by experiments involving H2O2 treatment (Limpose2018Overexpression).

NTHL1 also interacts with Y-box binding protein 1 (YB1), which enhances its AP-lyase activity without affecting its DNA glycosylase activity. This interaction is facilitated by the N-terminal domain of NTHL1 and is crucial for the coupling of its bifunctional activities. The interaction between NTHL1 and YB1 is significant in the context of drug resistance in cancer cells, as it may enhance DNA repair activity and contribute to resistance against chemotherapeutic agents like cisplatin (Senarisoy2020Förster).

These interactions highlight the role of NTHL1 in maintaining genomic stability and its potential impact on cancer development and treatment resistance.


## References


[1. (Pinto2023Combined) Carla Pinto, Joana Guerra, Manuela Pinheiro, Carla Escudeiro, Catarina Santos, Pedro Pinto, Miguel Porto, Carla Bartosch, João Silva, Ana Peixoto, and Manuel R. Teixeira. Combined germline and tumor mutation signature testing identifies new families with nthl1 tumor syndrome. Frontiers in Genetics, August 2023. URL: http://dx.doi.org/10.3389/fgene.2023.1254908, doi:10.3389/fgene.2023.1254908. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2023.1254908)

[2. (Weren2017NTHL1) Robbert DA Weren, Marjolijn JL Ligtenberg, Ad Geurts van Kessel, Richarda M De Voer, Nicoline Hoogerbrugge, and Roland P Kuiper. Nthl1 and mutyh polyposis syndromes: two sides of the same coin? The Journal of Pathology, 244(2):135–142, December 2017. URL: http://dx.doi.org/10.1002/path.5002, doi:10.1002/path.5002. This article has 68 citations.](https://doi.org/10.1002/path.5002)

3. (Carroll2021Caught) Caught in Motion: Human NTHL1 Undergoes Interdomain Rearrangement Necessary for Catalysis. This article has 0 citations.

[4. (Ikeda1998Purification) Shogo Ikeda, Tapan Biswas, Rabindra Roy, Tadahide Izumi, Istvan Boldogh, Alexander Kurosky, Altaf H. Sarker, Shuji Seki, and Sankar Mitra. Purification and characterization of human nth1, a homolog ofescherichia coli endonuclease iii. Journal of Biological Chemistry, 273(34):21585–21593, August 1998. URL: http://dx.doi.org/10.1074/jbc.273.34.21585, doi:10.1074/jbc.273.34.21585. This article has 182 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.273.34.21585)

5. (Hubers2024Functional) Functional Impact of Nth-like DNA glycosylase on Mitochondrial Dynamics. This article has 0 citations.

[6. (Limpose2018Overexpression) Kristin L Limpose, Kelly S Trego, Zhentian Li, Sara W Leung, Altaf H Sarker, Jason A Shah, Suresh S Ramalingam, Erica M Werner, William S Dynan, Priscilla K Cooper, Anita H Corbett, and Paul W Doetsch. Overexpression of the base excision repair nthl1 glycosylase causes genomic instability and early cellular hallmarks of cancer. Nucleic Acids Research, 46(9):4515–4532, March 2018. URL: http://dx.doi.org/10.1093/nar/gky162, doi:10.1093/nar/gky162. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gky162)

[7. (Senarisoy2020Förster) Muge Senarisoy, Caroline Barette, Françoise Lacroix, Salvatore De Bonis, Meike Stelter, Fabienne Hans, Jean-Philippe Kleman, Marie-Odile Fauvarque, and Joanna Timmins. Förster resonance energy transfer based biosensor for targeting the hnth1–yb1 interface as a potential anticancer drug target. ACS Chemical Biology, 15(4):990–1003, March 2020. URL: http://dx.doi.org/10.1021/acschembio.9b01023, doi:10.1021/acschembio.9b01023. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1021/acschembio.9b01023)

[8. (Boulouard2021Further) Flavie Boulouard, Edwige Kasper, Marie‐Pierre Buisine, Gwendoline Lienard, Stéphanie Vasseur, Sandrine Manase, Michel Bahuau, Emmanuelle Barouk Simonet, Virginie Bubien, Florence Coulet, Véronica Cusin, Marion Dhooge, Lisa Golmard, Vincent Goussot, Nadim Hamzaoui, Elodie Lacaze, Sophie Lejeune, Jacques Mauillon, Marie‐Pascale Beaumont, Stéphane Pinson, Camille Tlemsani, Christine Toulas, Jean‐Marc Rey, Nancy Uhrhammer, Gaëlle Bougeard, Thierry Frebourg, Claude Houdayer, and Stéphanie Baert‐Desurmont. Further delineation of the <scp>nthl1</scp> associated syndrome: a report from the french oncogenetic consortium. Clinical Genetics, 99(5):662–672, February 2021. URL: http://dx.doi.org/10.1111/cge.13925, doi:10.1111/cge.13925. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.13925)

[9. (Magrin2021POLE) Luigi Magrin, Daniele Fanale, Chiara Brando, Alessia Fiorino, Lidia Rita Corsini, Roberta Sciacchitano, Clarissa Filorizzo, Alessandra Dimino, Antonio Russo, and Viviana Bazan. Pole, pold1, and nthl1: the last but not the least hereditary cancer-predisposing genes. Oncogene, 40(40):5893–5901, August 2021. URL: http://dx.doi.org/10.1038/s41388-021-01984-2, doi:10.1038/s41388-021-01984-2. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-021-01984-2)

[10. (Das2020NTHL1) Lipsa Das, Victoria G. Quintana, and Joann B. Sweasy. Nthl1 in genomic integrity, aging and cancer. DNA Repair, 93:102920, September 2020. URL: http://dx.doi.org/10.1016/j.dnarep.2020.102920, doi:10.1016/j.dnarep.2020.102920. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.dnarep.2020.102920)

[11. (Nurmi2023NTHL1) Anna K. Nurmi, Liisa M. Pelttari, Johanna I. Kiiski, Sofia Khan, Mika Nurmikolu, Maija Suvanto, Niina Aho, Tiina Tasmuth, Eija Kalso, Johanna Schleutker, Anne Kallioniemi, Päivi Heikkilä, Aarno Palotie, Mark Daly, Bridget Riley-Gillis, Howard Jacob, Dirk Paul, Slavé Petrovski, Heiko Runz, Sally John, George Okafo, Nathan Lawless, Heli Salminen-Mankonen, Robert Plenge, Joseph Maranville, Mark McCarthy, Margaret G. Ehm, Kirsi Auro, Simonne Longerich, Anders Mälarstig, Katherine Klinger, Clement Chatelain, Matthias Gossel, Karol Estrada, Robert Graham, Robert Yang, Chris O’Donnell, Tomi P. Mäkelä, Jaakko Kaprio, Petri Virolainen, Antti Hakanen, Terhi Kilpi, Markus Perola, Jukka Partanen, Anne Pitkäranta, Taneli Raivio, Jani Tikkanen, Raisa Serpi, Tarja Laitinen, Veli-Matti Kosma, Jari Laukkanen, Marco Hautalahti, Outi Tuovila, Raimo Pakkanen, Jeffrey Waring, Fedik Rahimov, Ioanna Tachmazidou, Chia-Yen Chen, Zhihao Ding, Marc Jung, Shameek Biswas, Rion Pendergrass, David Pulford, Neha Raghavan, Adriana Huertas-Vazquez, Jae-Hoon Sul, Xinli Hu, Åsa Hedman, Manuel Rivas, Dawn Waterworth, Nicole Renaud, Ma’en Obeidat, Samuli Ripatti, Johanna Schleutker, Mikko Arvas, Olli Carpén, Reetta Hinttala, Johannes Kettunen, Arto Mannermaa, Katriina Aalto-Setälä, Mika Kähönen, Johanna Mäkelä, Reetta Kälviäinen, Valtteri Julkunen, Hilkka Soininen, Anne Remes, Mikko Hiltunen, Jukka Peltola, Minna Raivio, Pentti Tienari, Juha Rinne, Roosa Kallionpää, Juulia Partanen, Ali Abbasi, Adam Ziemann, Nizar Smaoui, Anne Lehtonen, Susan Eaton, Sanni Lahdenperä, Natalie Bowers, Edmond Teng, Fanli Xu, Laura Addis, John Eicher, Qingqin S. Li, Karen He, Ekaterina Khramtsova, Martti Färkkilä, Jukka Koskela, Sampsa Pikkarainen, Airi Jussila, Katri Kaukinen, Timo Blomster, Mikko Kiviniemi, Markku Voutilainen, Tim Lu, Linda McCarthy, Amy Hart, Meijian Guan, Jason Miller, Kirsi Kalpala, Melissa Miller, Kari Eklund, Antti Palomäki, Pia Isomäki, Laura Pirilä, Oili Kaipiainen-Seppänen, Johanna Huhtakangas, Nina Mars, Apinya Lertratanakul, Coralie Viollet, Marla Hochfeld, Jorge Esparza Gordillo, Fabiana Farias, Nan Bing, Margit Pelkonen, Paula Kauppi, Hannu Kankaanranta, Terttu Harju, Riitta Lahesmaa, Hubert Chen, Joanna Betts, Rajashree Mishra, Majd Mouded, Debby Ngo, Teemu Niiranen, Felix Vaura, Veikko Salomaa, Kaj Metsärinne, Jenni Aittokallio, Jussi Hernesniemi, Daniel Gordin, Juha Sinisalo, Marja-Riitta Taskinen, Tiinamaija Tuomi, Timo Hiltunen, Amanda Elliott, Mary Pat Reeve, Sanni Ruotsalainen, Audrey Chu, Dermot Reilly, Mike Mendelson, Jaakko Parkkinen, Tuomo Meretoja, Heikki Joensuu, Johanna Mattson, Eveliina Salminen, Annika Auranen, Peeter Karihtala, Päivi Auvinen, Klaus Elenius, Esa Pitkänen, Relja Popovic, Margarete Fabre, Jennifer Schutzman, Diptee Kulkarni, Alessandro Porello, Andrey Loboda, Heli Lehtonen, Stefan McDonough, Sauli Vuoti, Kai Kaarniranta, Joni A. Turunen, Terhi Ollila, Hannu Uusitalo, Juha Karjalainen, Mengzhen Liu, Stephanie Loomis, Erich Strauss, Hao Chen, Kaisa Tasanen, Laura Huilaja, Katariina Hannula-Jouppi, Teea Salmi, Sirkku Peltonen, Leena Koulu, David Choy, Ying Wu, Pirkko Pussinen, Aino Salminen, Tuula Salo, David Rice, Pekka Nieminen, Ulla Palotie, Maria Siponen, Liisa Suominen, Päivi Mäntylä, Ulvi Gursoy, Vuokko Anttonen, Kirsi Sipilä, Hannele Laivuori, Venla Kurra, Laura Kotaniemi-Talonen, Oskari Heikinheimo, Ilkka Kalliala, Lauri Aaltonen, Varpu Jokimaa, Marja Vääräsmäki, Outi Uimari, Laure Morin-Papunen, Maarit Niinimäki, Terhi Piltonen, Katja Kivinen, Elisabeth Widen, Taru Tukiainen, Niko Välimäki, Eija Laakkonen, Jaakko Tyrmi, Heidi Silven, Eeva Sliz, Riikka Arffman, Susanna Savukoski, Triin Laisk, Natalia Pujol, Janet Kumar, Iiris Hovatta, Erkki Isometsä, Hanna Ollila, Jaana Suvisaari, Thomas Damm Als, Antti Mäkitie, Argyro Bizaki-Vallaskangas, Sanna Toppila-Salmi, Tytti Willberg, Elmo Saarentaus, Antti Aarnisalo, Elisa Rahikkala, Kristiina Aittomäki, Fredrik Åberg, Mitja Kurki, Aki Havulinna, Juha Mehtonen, Priit Palta, Shabbeer Hassan, Pietro Della Briotta Parolo, Wei Zhou, Mutaamba Maasha, Susanna Lemmelä, Aoxing Liu, Arto Lehisto, Andrea Ganna, Vincent Llorens, Henrike Heyne, Joel Rämö, Rodos Rodosthenous, Satu Strausz, Tuula Palotie, Kimmo Palin, Javier Gracia-Tabuenca, Harri Siirtola, Tuomo Kiiskinen, Jiwoo Lee, Kristin Tsuo, Kati Kristiansson, Kati Hyvärinen, Jarmo Ritari, Katri Pylkäs, Minna Karjalainen, Tuomo Mantere, Eeva Kangasniemi, Sami Heikkinen, Nina Pitkänen, Samuel Lessard, Clément Chatelain, Lila Kallio, Tiina Wahlfors, Eero Punkka, Sanna Siltanen, Teijo Kuopio, Anu Jalanko, Huei-Yi Shen, Risto Kajanne, Mervi Aavikko, Helen Cooper, Denise Öller, Rasko Leinonen, Henna Palin, Malla-Maria Linna, Masahiro Kanai, Zhili Zheng, L. Elisa Lahtela, Mari Kaunisto, Elina Kilpeläinen, Timo P. Sipilä, Oluwaseun Alexander Dada, Awaisa Ghazal, Anastasia Kytölä, Rigbe Weldatsadik, Kati Donner, Anu Loukola, Päivi Laiho, Tuuli Sistonen, Essi Kaiharju, Markku Laukkanen, Elina Järvensivu, Sini Lähteenmäki, Lotta Männikkö, Regis Wong, Auli Toivola, Minna Brunfeldt, Hannele Mattsson, Sami Koskelainen, Tero Hiekkalinna, Teemu Paajanen, Kalle Pärn, Mart Kals, Shuang Luo, Shanmukha Sampath Padmanabhuni, Marianna Niemi, Mika Helminen, Tiina Luukkaala, Iida Vähätalo, Jyrki Tammerluoto, Sarah Smith, Tom Southerington, Petri Lehto, Kristiina Aittomäki, Carl Blomqvist, and Heli Nevanlinna. Nthl1 is a recessive cancer susceptibility gene. Scientific Reports, November 2023. URL: http://dx.doi.org/10.1038/s41598-023-47441-w, doi:10.1038/s41598-023-47441-w. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-023-47441-w)